MyVisionTest News Archive

Google
 
   

News Tag Cloud

ADL skills adverse drug effects AMD animal study AREDS Avastin blindness brain science cardiovascular disease cataract CATT central serous chorioretinopathy clinical trial CNV combo therapy complement depression diabetes diabetic retinopathy diet dosing strategy drug delivery dry AMD eccentric viewing endophthalmitis eye drops fish fluorescein angiography fundus autofluorescence genetics Germany histoplasmosis ICGA Japan laser photocoagulation lipofuscin low vision Lucentis lutein Macugen macular edema microplasmin mobility myopia neuroprotection obesity OCT oxidative stress PDGF photodynamic therapy pigment epithelial detachment polypoidal choroidal vasculopathy preferred retinal locus prognosis PrONTO Quality of life racial differences radiation reading skills retinal angiomatous proliferation retinal prosthesis retinal vein occlusion retinitis pigmentosa RNA interference RPE RPE tear stem cells steroid surgery tachyphylaxis tobacco UK uveitis VEGF VEGF Trap vision test visual cycle vitreous wet AMD women
More topics

Recent News

Retinal angiomatous proliferation
Feb 25, 2010
Compared with combination therapy of intravitreal triamcinolone (IVTA) plus photodynamic therapy (PDT), intravitreal Avastin (IVB) plus PDT was significantly more effective in maintaining and improving visual acuity and in reducing the number of treatment for patients with retinal angiomatous proliferation (RAP), according to a new study....

Full Article


Central Serous Chorioretinopathy
Feb 24, 2010
Photodynamic therapy (PDT) is not effective in eyes with chronic central serous chorioretinopathy (CSC) without intense hyperfluorescence on indocyanine green angiography (ICGA), according to a new study. Central serous chorioretinopathy (CSC) is commonly seen in young or middle-aged adults as localized detachment of the neurosensory retina....

Full Article


Age-related macular degeneration
Feb 24, 2010
There is no difference in the visual acuity (VA) outcomes after Avastin (bevacizumab) or Lucentis (ranibizumab) treatment for AMD, according to a new study. In 2006, the United States Food and Drug Administration approved the use of Lucentis (ranibizumab) for the treatment of exudative AMD. Before its approval, many ophthalmologists already...

Full Article


Myopic macular degeneration
Feb 23, 2010
There is no significant difference the short-term efficacy and safety of intravitreal Lucentis (ranibizumab) versus Avastin (bevacizumab) in treating myopic choroidal neovascularization (CNV), according to a new study. Choroidal neovascularization (CNV) secondary to pathologic myopia causes severe visual loss in young and middle-aged patients....

Full Article


DNA double-helix molecule
Feb 23, 2010
A mathematical model has been developed to predict the absolute risk of geographic atrophy and neovascular age-related macular degeneration (AMD) risk based on smoking history and genetic risk factors in individuals of European ancestry. Although AMD was long thought to have primarily an environmental etiology, genetic variation is now known...

Full Article


Vitrectomy
Feb 21, 2010
Intravitreal Avastin (bevacizumab, IVB) injection as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy (PDR) improves the anatomical and functional outcomes of surgery, according to a new study. Diabetic retinopathy is the result of microvascular retinal changes. Hyperglycemia-induced pericyte death and...

Full Article


Pigment epithelial detachment
Feb 21, 2010
Combined intravitreal triamcinolone acetonide (IVTA) injection with intravitreal Avastin (bevacizumab, IVB) is effective in the treatment of choroidal neovascularization (CNV) associated with large retinal pigment epithelial detachment (PED) in age-related macular degeneration (AMD), according to a new study. A PED occurs when fluid enters the...

Full Article


Laboratory glassware
Feb 20, 2010
Avastin impairs phagocytic activity of retinal pigment epithelial (RPE) cells cultured in a laboratory, according to a new study. The retinal pigment epithelium (RPE) is a layer of "nurse cells" located immediately adjacent to the photoreceptors that provide the photoreceptors with nourishment and removes their waste products. The...

Full Article


Myopic macular degeneration
Feb 20, 2010
A study comparing the outcomes of laser treatment (LT), photodynamic therapy (PDT) with verteporfin, and intravitreal Avastin (bevacizumab) in patients with juxtafoveal choroidal neovascularization (CNV) secondary to pathologic myopia finds that Avastin offers the best functional results during a 2-year follow-up. Pathologic myopia is a major...

Full Article


Laboratory mouse
Feb 19, 2010
Albino rats develop progressive stages of retinal degeneration and CNV after long-term intense cyclic light exposure, allowing the detailed study of the pathogenesis and treatment of age-related macular degeneration (AMD), according to a new research report. Animal models of AMD that manifest some of the features of human AMD have become...

Full Article


Reading
Feb 18, 2010
Older adults experience some benefit, but less than young adults, from training to use their peripheral vision to read text, according to a new study. Enhancing reading ability in peripheral vision is important for the rehabilitation of people with central-visual-field loss from age-related macular degeneration (AMD). Previous research has...

Full Article


Diabetes
Feb 18, 2010
A single injection of triamcinolone (steroid) was as effective as 3 monthly injections of Avastin (bevacizumab) for the treatment of patients with diabetic macular edema, according to a new study. The traditional treatment for diabetic macular edema is laser photocoagulation. Both steroids and Avastin have been reported to have benefitial...

Full Article